In a report published Thursday, Citigroup analyst Ashwin Shirvaikar reiterated a Buy rating on Amdocs DOX, and raised the price target from $41.00 to $44.00.
In the report, Citigroup noted, “DOX remains a Buy and we are modestly raising our price target to $44 from $41 as we move the valuation basis to FY14 from FY13….We note this is not the place for excitement from an operating results perspective…DOX had in-line results (vs. consensus). 4Q-FY13 guidance ranges straddled expectations and were slightly ahead of fiscal 3Q13 performance (once we offset the 3Q, 4Q tax rate impact). It signed a major European contract - should help European revenues that had been criticized for lagging – but ‘Rest of World' revenues tailed off – slowing sub growth and economic malaise are equally to blame here. N. America gets steadily better but sector-M&A-related revenues are a FY14 (not FY13) event. Lastly, cash continues to build on the bal sheet despite the ongoing buyback – we would not rule out a greater dividend in a quarter or so. We look for the stock to appreciate steadily over time.”
Amdocs closed on Wednesday at $38.47.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.